Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Tonje Thorvaldsen , Lars H Lund Added: 3 years ago
Heart failure (HF) is associated with poor quality of life, high risk of death and is the leading cause of hospitalisation.1 With an ageing population and improved care for cardiovascular diseases, the prevalence of HF is increasing. Despite advances in HF therapies, 1–10% of the population with HF progress to an advanced stage of the disease.2,3 In the US, an estimated 250,000–300,000 patients… View more
Professor Michael Jenkins trained at the Middlesex Hospital, London and qualified in 1989 as the Broderip Scholar. He trained in surgery at Charing Cross, University College London, the Royal Brompton and Royal Free hospitals and was awarded the Gold medal at FRCS. Appointed as a consultant to St Mary’s and Chelsea and Westminster hospitals in 2001, he has since developed both a local and a… View more
Job title: Director of Cardiovascular Innovation
Dr. Dangas is a Professor of Medicine (Cardiology) and Surgery (Vascular) at the Icahn School of Medicine at Mount Sinai, Director of Cardiovascular Innovation at the Cardiovascular Institute of the Mount Sinai Medical Center, New York City, and the Director of the Medical School Course Cardiology. He is a Founding Physician of the Cardiovascular Research Foundation in New York City. George is… View more
Author(s): Alexander Fanaroff Added: 5 months ago
Stay up-to-date with the latest data in cardiovascular science with the help of renowned experts and emerging voices who offer concise summaries, in-depth discussions, and critical reviews to keep you informed.In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. With their keen awareness of… View more
Every week in the UK at least 12 young people die of undiagnosed heart conditions. Since its formation in 1995, Cardiac Risk in the Young (CRY) has been working to reduce the frequency of young sudden cardiac death (YSCD). CRY supports young people diagnosed with potentially life-threatening cardiac conditions and offers bereavement support to families affected by YSCD. CRY promotes and develops… View more
Research Area(s) / Expertise:

Anticoagulation

Stroke Prevention in Atrial Fibrillation

Job title: Consultant Pharmacist & Lead Cardiovascular Pharmacist
Mr Sotiris Antoniou is Consultant Pharmacist at Barts Heart Centre, part of Barts Health NHS Trust. Combined with his role as Lead Cardiovascular Pharmacist for UCL Partners supports medicines optimisation across the health economy to optimise patient outcomes and address unmet local needs. He is an independent prescriber and is currently chair of the cardiac committee for United Kingdom Clinical… View more
Job title: Consultant Vascular and Endovascular Surgeon
Dr Morad Sallam is a consultant vascular surgeon at Guy’s and St Thomas’ NHS Foundation Trust (GSTT), London, UK. He is the head of education and training in vascular urgery at GSTT and an honorary senior lecturer at King’s College London. He held various education leadership roles and is currently the cardiovascular block lead for KCL medical students at GSTT. Dr Sallam graduated in 2003 with… View more
Author(s): Stefan Spitzer Added: 2 years ago
Identify which patient groups are most likely to benefit from Atrial Fibrillation ablation and the optimal time for patient referral in this video with Professor Dr Stefan Spitzer. Key Learning Objectives: Which patients are likely to benefit most from ablation When to refer for ablation Practical guidance for improving access to ablation for relevant patients Additional Learning… View more
Foreword

Article

Author(s): Andrew JS Coats , Giuseppe Rosano Added: 3 years ago
It is with great pleasure that we introduce to you, our readers, to the first issue of Cardiac Failure Review for 2019. This issue features a range of articles on major areas of advance in heart failure from renowned experts. Some of the most topical areas in the management of heart failure are the effects and treatment of co-morbidities, and none more so than diabetes. In this issue, Thomas A… View more